Page 42 - Pharma
BioMarin buys global rights to phenylketonuria franchise from Merck
Merck to receive upfront payment of Euro 340 million, plus up to Euro 185 million in additional milestones, for selling the rights of Kuvan and pegvaliase to BioMarin
 "BioMarin buys global rights to phenylketonuria franchise from Merck")
Teva Pharma acquires Mexican firm Rimsa for $2.3 bn
With this acquisition, Teva will become a leading pharmaceutical company in Mexico, the second largest market in Latin America and one of the top five emerging markets globally
 "Teva Pharma acquires Mexican firm Rimsa for $2.3 bn")
Biocon acquires production facility of Acacia Lifesciences
Located at Vishakapatnam, the unit is presently manufacturing advanced intermediates of potent APIs useful to Biocon's business as well as for supply to third party customers
 "Biocon acquires production facility of Acacia Lifesciences")
Evonik plans to build additional methionine plant in Singapore
The facility, which will produce the amino acid DL-methionine for animal nutrition, will have an annual production capacity of 150,000 metric tonnes
 "Evonik plans to build additional methionine plant in Singapore")
Solvay expands capacity of Novecare's surfactant plants in India
The Belgian firm also aims to double the size of its application lab in Mumbai in the next 3-4 years to support its Novecare business in the country
 "Solvay expands capacity of Novecare's surfactant plants in India")
US-based Sealed Air opens global R&D center in Mumbai
The new facility houses Sealed Air's global R&D centers for fabric care & food and beverage hygiene solutions, and an Indian packaging solution center
 "US-based Sealed Air opens global R&D center in Mumbai")
German investor Paragon Partners buys Balda AG for Euro 62.9 mn
Paragon will maintain the current strategic orientation and organisational structure and retain the management of Balda AG
 "German investor Paragon Partners buys Balda AG for Euro 62.9 mn")
Dishman to supply API for Janssen Pharma's TB drug Sirturo
The Ahmedabad-based Dishman has recently started supplying the API to Janssen from its Bavla facility, where it has the capacity to make 5 tonnes of the API per month
 "Dishman to supply API for Janssen Pharma's TB drug Sirturo")
Merck and Pfizer to collaborate with Agilent arm Dako for avelumab
Two pharm companies will collaborate with Dako in developing an immunohistochemistry (IHC)-based companion diagnostic (CDx) in immuno-oncology
 "Merck and Pfizer to collaborate with Agilent arm Dako for avelumab")
What's driving mergers and acquisitions in pharma industry?
Not all mergers result in profitable outcome. However, mergers are critical for the long terms benefits of the pharmaceutical industry and for its short and long term survival
 "What's driving mergers and acquisitions in pharma industry?")
US FDA revokes approval for Sun Pharma's epilepsy drug
Approval for Elepsia XR (Levetiracetam extended-release tablets) was revoked due to regulatory compliance issues at Sun Pharma's Halol plant
 "US FDA revokes approval for Sun Pharma's epilepsy drug")
Dr Reddy's launches esomeprazole DR capsules in US
As per IMS Health, Nexium (esomeprazole magnesium) delayed-release capsules brand and generic had US sales of about $5.2 billion for the last twelve months ending in July 2015
 "Dr Reddy's launches esomeprazole DR capsules in US")
US FDA grants approval to Granules India for ibuprofen tabs
The move will further strengthen its base business and enable us to increase its products offering in the US
 "US FDA grants approval to Granules India for ibuprofen tabs")
Jubilant Life receives US FDA approval for migraine drug zomitriptan
Zolmitriptan orally disintegrating tablet is the generic version of Astra Zeneca's Zomig-ZMT
Novo Nordisk to set up insulin pen manufacturing plant in Iran
The company will invest approximately Euro 70 million for the project
 "Novo Nordisk to set up insulin pen manufacturing plant in Iran")
Amgen acquires Dutch biotech firm Dezima for $ 300 mn
Besides $300 million, Amgen will pay Dezima up to $1.25 billion in additional payments if certain development and sales milestones are achieved
Strides Arcolab buys Ranbaxy's CNS biz from Sun Pharma for Rs 165 cr
By acquiring Solus and Solus Care divisions of erstwhile Ranbaxy, Strides Arcolab will gain a strong entry point in the Indian CNS market
Dutch firm Corbion buys lactic acid business of Malladi Specialties
While the transaction includes the sales and delivery of lactic acid and lactic acid based derivatives in India, no production facilities will be acquired by Corbion
 "Dutch firm Corbion buys lactic acid business of Malladi Specialties")
Sun Pharma buys InSite Vision to strengthen ophthalmic business in US
This proposed acquisition of InSite Vision, coupled with the recent in-licensing of Xelpros eye drop in June 2015, are expected to strengthens branded ophthalmic portfolio
 "Sun Pharma buys InSite Vision to strengthen ophthalmic business in US")
Glenmark's bi-specific antibody to enter phase I trials
With the addition of GBR 1302 to the pipeline, Glenmark has now four monoclonal antibodies in the novel biologics entity (NBE) pipeline with three of them undergoing active clinical development
 "Glenmark's bi-specific antibody to enter phase I trials")